DirectoryMix Web Resources » Article Details

Misonix Announces New Distribution Agreement for Sonablate - Read More

Date Added: July 17, 2008 01:24:02 AM
FARMINGDALE, N.Y.----Misonix, Inc. , a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of cancer and worldwide for other acute health conditions, has entered into a new, three year, exclusive distribution agreement with privately-held Intermedica of Nizhny Novgorod, Russia for the distribution of the Sonablate 500 High Intensity ...

Category: Health » Procedures and Therapies


No comments are posted yet


 
Name:*
Email:*
Website:  (optional)
Comment:*
(html and bb codes are filtered and not allowed)

Do the math:*CAPTCHA - Do The Math
 

Related Articles

Local chiropractor makes adjustment

Chiropractic physician Dr. Darren Cissell, of Channahon, is venturing off on his own to open a private practice in Minooka. Cissell will take over Ridge Chiropractic, formerly owned by Dr. Todd Roach.

ASPS Study Predicts Cosmetic Surgery Procedures To Exceed 55 Million In 2015

More than 55 million cosmetic surgery procedures will be performed in 2015, predicts a recent study in Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). This more than quadruples the num

Editors Memo

Does dark matter cause ACL injuries? I see two types of dark matter on our radar. One is quite exciting, at least to this former astronomy major, and one is potentially catastrophic.

Congress Passes Bill Barring Genetic Discrimination [News]

The House today passed a measure by a whopping 414-to-1 margin that would prohibit health insurers from canceling or denying coverage or hiking premiums based on a genetic predisposition to a specific disease. The legislation, the Genetic Information Nond

Leading Medical Experts Gather For 1st World Congress On Interventional Therapies For Type 2 Diabetes

The 1st World Congress on Interventional Therapies for Type 2 Diabetes will bring together leading experts in diabetes, endocrinology, surgery and public health to discuss the role of surgery and novel interventional therapies in the treatment of type 2 d